1. Home
  2. RR vs ARVN Comparison

RR vs ARVN Comparison

Compare RR & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$2.72

Market Cap

614.9M

Sector

N/A

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$9.09

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
ARVN
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
614.9M
658.2M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
RR
ARVN
Price
$2.72
$9.09
Analyst Decision
Hold
Buy
Analyst Count
2
19
Target Price
$4.00
$15.05
AVG Volume (30 Days)
10.6M
761.4K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
$5,045,000.00
$262,600,000.00
Revenue This Year
$75.68
N/A
Revenue Next Year
$78.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.99
N/A
52 Week Low
$1.73
$6.06
52 Week High
$7.43
$14.22

Technical Indicators

Market Signals
Indicator
RR
ARVN
Relative Strength Index (RSI) 55.53 31.52
Support Level $1.84 $9.02
Resistance Level $2.82 $10.18
Average True Range (ATR) 0.22 0.65
MACD 0.02 -0.07
Stochastic Oscillator 52.08 8.30

Price Performance

Historical Comparison
RR
ARVN

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: